Literature DB >> 15506586

Changing prescribing patterns and increasing prescription expenditures in Medicaid.

Kenneth S Fink1, Patricia J Byrns.   

Abstract

PURPOSE: Prescription drug expenditures are the most rapidly growing component of total health care expenditures and particularly affect state Medicaid programs. We determined the extent to which increasing prescription price and changing prescribing patterns contribute to rising prescription expenditures in Medicaid.
METHODS: We conducted a claims-based analysis comparing annual prescription drug expenditures and prescribing patterns. Prescription drug and outpatient visit claims for all North Carolina Medicaid enrollees from 1998 through 2000 were included. We analyzed drugs individually by combining all prescriptions and expenditures for the same drug formulation, and we calculated the number of units dispensed per person-year of enrollment.
RESULTS: Prescription drug coverage for 1 person-year cost 503 dollars in 1998 and 759 dollars in 2000, for an annual increase of 22.8%. The average number of prescriptions filled per person-year increased from 13.0 in 1998 to 15.5 in 2000. Increased prescribing for 6 drugs accounted for more than 25% of the total increase in expenditures. The price for the 15 most expensive drugs increased an average of 4.1% annually.
CONCLUSIONS: Prices for existing drugs increased slightly during the study period, but the major cause of the increase in drug costs was an increase in the number of prescriptions for new and more expensive medications. Prescribing patterns in Medicaid differ somewhat from those in the private sector and partly reflect the population with low socioeconomic status and high health care needs that it serves. To help control rising prescription drug expenditures, efforts should be undertaken to improve appropriate and cost-effective prescribing.

Entities:  

Mesh:

Year:  2004        PMID: 15506586      PMCID: PMC1466712          DOI: 10.1370/afm.121

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  7 in total

1.  Explaining drug spending trends: does perception match reality?

Authors:  R W Dubois; A J Chawla; C A Neslusan; M W Smith; S Wade
Journal:  Health Aff (Millwood)       Date:  2000 Mar-Apr       Impact factor: 6.301

Review 2.  Direct-to-consumer prescription drug advertising: trends, impact, and implications.

Authors:  M S Wilkes; R A Bell; R L Kravitz
Journal:  Health Aff (Millwood)       Date:  2000 Mar-Apr       Impact factor: 6.301

3.  Promotion of prescription drugs to consumers.

Authors:  Meredith B Rosenthal; Ernst R Berndt; Julie M Donohue; Richard G Frank; Arnold M Epstein
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

4.  The American health care system--expenditures.

Authors:  J K Iglehart
Journal:  N Engl J Med       Date:  1999-01-07       Impact factor: 91.245

5.  A critical analysis of studies of state drug reimbursement policies: research in need of discipline.

Authors:  S B Soumerai; D Ross-Degnan; E E Fortess; J Abelson
Journal:  Milbank Q       Date:  1993       Impact factor: 4.911

6.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

7.  Trends in Medicaid prescription drug utilization and payments, 1990-97.

Authors:  D K Baugh; P L Pine; S Blackwell
Journal:  Health Care Financ Rev       Date:  1999
  7 in total
  2 in total

1.  Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals.

Authors:  Alexandra Prados-Torres; Amaia Calderón-Larrañaga; Antoni Sicras-Mainar; Sebastià March-Llull; Bárbara Oliván-Blázquez
Journal:  BMC Health Serv Res       Date:  2009-11-18       Impact factor: 2.655

Review 2.  Systematic review on quality control for drug management programs: is quality reported in the literature?

Authors:  Anke-Peggy Holtorf; Carrie McAdam-Marx; David Schaaf; Benjamin Eng; Gary Oderda
Journal:  BMC Health Serv Res       Date:  2009-02-25       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.